Covid-19 and radiotherapy: a systematic review after 2 years of pandemic
- PMID: 35910079
- PMCID: PMC9308500
- DOI: 10.1007/s40336-022-00513-9
Covid-19 and radiotherapy: a systematic review after 2 years of pandemic
Abstract
Introduction: Following the Covid-19 pandemic spread, changes in clinical practice were necessary to limit the pandemic diffusion. Also, oncological practice has undergone changes with radiotherapy (RT) treatments playing a key role.Although several experiences have been published, the aim of this review is to summarize the current evidence after 2 years of pandemic to provide useful conclusions for clinicians.
Methods: A Pubmed/MEDLINE and Embase systematic review was conducted. The search strategy was "Covid AND Radiotherapy" and only original articles in the English language were considered.
Results: A total of 2.733 papers were obtained using the mentioned search strategy. After the complete selection process, a total of 281 papers were considered eligible for the analysis of the results.
Discussion: RT has played a key role in Covid-19 pandemic as it has proved more resilient than surgery and chemotherapy. The impact of the accelerated use of hypofractionated RT and telemedicine will make these strategies central also in the post-pandemic period.
Keywords: Covid-19; Oncological practice; Radiotherapy.
© The Author(s), under exclusive licence to Italian Association of Nuclear Medicine and Molecular Imaging 2022.
Conflict of interest statement
Conflict of interestAll authors declare no conflicts of interests.
Figures
Similar articles
-
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review.Oncol Res Treat. 2023;46(3):116-123. doi: 10.1159/000528640. Epub 2022 Dec 12. Oncol Res Treat. 2023. PMID: 36509043
-
Is Teledentistry a Method for Optimizing Dental Practice, Even in the Post-Pandemic Period? An Integrative Review.Int J Environ Res Public Health. 2022 Jun 22;19(13):7609. doi: 10.3390/ijerph19137609. Int J Environ Res Public Health. 2022. PMID: 35805267 Free PMC article. Review.
-
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z. Trials. 2021. PMID: 33419461 Free PMC article.
-
Impact of COVID-19 in gynaecological oncology care: a systematic rapid review.Arch Gynecol Obstet. 2022 Mar;305(3):555-565. doi: 10.1007/s00404-021-06295-1. Epub 2021 Nov 3. Arch Gynecol Obstet. 2022. PMID: 34729631 Free PMC article. Review.
-
Current and future use of telemedicine in surgical clinics during and beyond COVID-19: A narrative review.Ann Med Surg (Lond). 2021 Jun;66:102378. doi: 10.1016/j.amsu.2021.102378. Epub 2021 May 8. Ann Med Surg (Lond). 2021. PMID: 33996071 Free PMC article. Review.
Cited by
-
Magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT) for oligometastatic patients: a single-center experience.Radiol Med. 2023 May;128(5):619-627. doi: 10.1007/s11547-023-01627-4. Epub 2023 Apr 20. Radiol Med. 2023. PMID: 37079221 Free PMC article.
-
Treatment of oropharyngeal cancer during the COVID-19 lockdown - outcomes for patients treated during the pandemic.Rep Pract Oncol Radiother. 2024 Dec 4;29(5):606-613. doi: 10.5603/rpor.103236. eCollection 2024. Rep Pract Oncol Radiother. 2024. PMID: 39759557 Free PMC article.
-
The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era.Front Oncol. 2022 Sep 14;12:976143. doi: 10.3389/fonc.2022.976143. eCollection 2022. Front Oncol. 2022. PMID: 36185295 Free PMC article. Review.
-
Time Reveals the Truth! What Treatments for COVID-19 Were Quickly Abandoned, and Which Methods, Contrary to Popular Belief, Are Still Flourishing?J Biomed Phys Eng. 2024 Dec 1;14(6):599-606. doi: 10.31661/jbpe.v0i0.2206-1514. eCollection 2024 Dec. J Biomed Phys Eng. 2024. PMID: 39726888 Free PMC article.
-
Radiotherapy for non-cancer diseases: benefits and long-term risks.Int J Radiat Biol. 2024;100(4):505-526. doi: 10.1080/09553002.2023.2295966. Epub 2024 Jan 5. Int J Radiat Biol. 2024. PMID: 38180039 Free PMC article. Review.
References
-
- WHO Coronavirus (Covid-19) Dashboard. https://covid19.who.int. Accessed 30 Jan 2022.
Publication types
LinkOut - more resources
Full Text Sources